12915576.txt 0 existence   transdominant   potentiating mutants   ul9   herpes simplex virus type 1 originbinding protein suggests   levels   ul9 protein may   regulated during infection
12915576.txt 1 ul9     multifunctional protein required   herpes simplex virus type 1 hsv1 replication   vivo ul9     member     superfamily ii helicases   exhibits helicase   originbinding activities   have previously shown   mutations     conserved helicase motifs   ul9 can have either   transdominant   potentiating effect     plaqueforming ability   infectious dna   wildtype virus   j malik   s k weller j virol 7078597866 1996     paper   mechanisms   transdominance   potentiation   explored   show     motif v mutant protein containing   g     substitution   residue 354   unstable when expressed   transfection     either processed     38kda nterminal fragment   degraded completely   overexpression     mv mutant protein   able   influence   steadystate protein levels   wildtype ul9     override   inhibitory effects   wildtype ul9 potentiation correlates     ability     ul9 variants containing   g354a mutation     processed   degraded     38kda form   propose     mv mutant protein   able   interact   fulllength ul9       interaction results     decrease     steadystate levels   ul9     turn leads   enhanced viral infection furthermore   demonstrate   inhibition   hsv1 infection can   obtained   overexpression   fulllength ul9   cterminal third     protein containing   originbinding domain     nterminal twothirds   ul9 containing   conserved helicase motifs     putative dimerization domain   results suggest   transdominance can   mediated   overexpression originbinding activity   dimerization whereas potentiation   most likely caused     ability     ul9 mv mutant   influence   steadystate levels   wildtype ul9 taken together   results presented     paper suggest     regulation   steadystate levels   ul9 may play an important role   controlling viral infection
12915576.txt 2 
12915576.txt 3   ul9 gene   required   herpes simplex virus type 1 hsv1 replication   vivo    ul9 protein     dimer   solution   exhibits helicase atpase   originbinding activities  ul9   believed   play   key role     initiation   hsv1 replication   binding   hsv1 origin   replication via its cterminal domain   unwinding       presence   atp   icp8   hsv1 singlestranded dna binding protein     likely   ul9 plays an important role     assembly     viral replisome  through its interactions   other viral replication proteins  ul9     member     superfamily ii helicases    conserved helicase motifs     characteristic     superfamily   positioned within   nterminal domain     protein  genetic studies have previously shown   conserved residues within   helicase motifs   essential   hsv1 replication   vivo most engineered motif mutants fail   complement   growth   hr94   ul9 null virus  furthermore biochemical analysis showed   correlation between   failure   complement hr94     lack   helicase activity  indicating   helicase activity   essential   ul9 function interestingly   truncated form   ul9 originating     unique transcript within   ul9 open reading frame designated ul85   obpc has been observed  obpc encompasses   480 cterminal amino acids   ul9     able   bind   origin   replication   localizes     nucleus   its significance     biology     hsv1     well understood several lines   evidence indicate   overexpression   ul9 can inhibit hsv1 infection   previously showed   cell lines containing   low copy number     wildtype ul9 gene could efficiently complement hr94 whereas cell lines harboring   high copy number exhibited lower levels   complementation    addition cell lines harboring   high copy number     ul9 gene were found   inhibit wildtype hsv1 infection  furthermore   cotransfection   wildtype infectious dna   an excess   plasmid encoding wildtype ul9 reduced   number   plaques observed compared   transfection   wildtype infectious dna alone    inhibitory effect   wildtype ul9 overexpression   mediated   least   part     originspecific dna binding function   ul9 harbored     cterminal domain ul9 ctd     plaque reduction assay ul9 ctd severely reduces   efficiency   plaque formation      thus considered transdominant dominant negative   ob mutation   disrupts   originbinding activity   ul9 reverses   inhibitory effect   wildtype ul9   well     transdominant effect   ul9 ctd    inhibitory properties     overexpressed wildtype ul9   consistent     model     hsv1 dna replication occurs   two steps   stages  according     model early   infection hsv1 replication initiates     ul9dependent process   one     origins   replication stage   later   infection replication proceeds   an originindependent manner stage ii   have proposed     ul9 remains bound     origin   replication late   infection   may inhibit   transition between stage     stage ii  consistent     model studies   temperaturesensitive ul9 mutants indicate   ul9   essential     early stages   hsv1 replication   appears     dispensable     later ones  according     scenario   speculate     may   necessary   downregulate   levels   ul9 protein during stage ii   order   infection   proceed   characterization   transdominant dominant negative mutants     widely employed genetic approach   gain insight into protein function  mutations   ul9 helicase motifs   ia ii   vi were previously shown     transdominant     plaque reduction assay  ul9 mutant proteins bearing mutations   helicase motifs   ia ii   vi   able   dimerize   bind   origin   replication     defective   helicase activity    proposed     transdominance exhibited   these mutants     result   inhibition   hsv1 replication   stage   due   lack   helicase activity   inhibition     transition between stage     stage ii due   overexpression   protein capable   binding   origin   proposed above   wildtype ul9   contrast     transdominant mutations   helicase motifs   ia ii   vi   mutation   motif v g354a was found   confer   potentiating phenotype when cells were cotransfected     mutant   wildtype infectious dna   plaque number increased compared   transfection   wildtype infectious dna alone  interestingly   stable mutant protein could   detected     transient transfectionwestern blot assay  intrigued     ability   an apparently unstable protein   potentiate hsv1 infection   sought   further understand   mechanism   potentiation     paper   show     ability     ul9 g234a motif v mutation   potentiate hsv1 infection inversely correlates   protein stability   overexpression   ul9mv   able   reduce   steadystate wildtype ul9 protein levels   override its inhibitory effects furthermore   report     fragment consisting     nterminal 535 amino acids   ul9   also transdominant based     genetic   biochemical properties   ul9 helicase motif mutants   propose   model     mechanism   transdominance   potentiation
12915576.txt 4 reagents   materials    restriction enzymes were purchased   new england biolabs   pfastbac vector was purchased   gibcobrl   pcdna1   pcdna3 vectors were   invitrogen supplemented graces medium   penicillinstreptomycin were purchased   gibcobrl fetal calf serum was   gemini bioproducts inc  viruses   cells  hsv1 strain kos was used     wildtype virus     assays hr94   ul9 lacz insertion mutant was described previously  vero cells american type culture collection   2b11   veroderived cell line stably transfected   wildtype ul9  were maintained   dulbeccos modified eagles medium   described previously  spodoptera frugiperda sf21 insect cells were maintained   serumfree medium containing 01 mg   streptomycin per ml   100 units   penicillin per ml escherichia coli dh5alpha cells were used   plasmid amplification dh10bac competent cells gibcobrl were used   bacmid packaging   propagation  antibodies  several antiul9 antibodies were used     study r250   kind gift   m challberg national institutes   health     polyclonal antibody   recognizes   cterminal 10 amino acids   ul9 17b     monoclonal antibody   recognizes   nterminal 35 amino acids   ul9    rh7   kind gift     tenney bristol meyers squib was raised against   glutathione stransferase fusion     ul9 cterminal domain residues 535   851   polyclonal antiul6 antibody was described previously  antiau1 tag antibody was purchased   babco berkeley calif   polyclonal antiicp8 antibody was   kind gift   w ruyechan state university   new york buffalo ny  fluorescein isothiocyanateconjugated antimouse   antirabbit immunoglobulin   texas redconjugated antimouse   antirabbit immunoglobulin antibodies were used   secondary antibodies   immunofluorescence analysis commercially available antitubulin antibody sigma was used   western blot analysis   monitor sample loading anti  tag india probe pierce was used   detect  tagged ul9 fusions  plasmids    pfastbac transfer vectors were used   generate recombinant baculoviruses bearing   cterminal 317 amino acids   ul9 pfastbacul9ct     nterminal 535 amino acids   ul9 pfastbacul9nt   bamhi   ecoridigested pcr product containing   c terminus ul9ct was inserted     pfastbac plasmid   generate pfastbacul9ct   pcr product was amplified   stepdown pcr    pfastbacul9wtexpressing plasmid     template     following oligonucleotides bamhiul9delta1534 5gccgaggtggatccatggatcccgaggcgtcgctgccggccca3   3pclpfastbac 5gattatgatcctctagtacttctc3   pfastbacul9nt plasmid was generated   cloning   bamhi   ecoridigested pcr product containing ul9nt into   pfastbac plasmid   ul9nt pcr fragment was amplified   stepdown pcr     pfastbacul9wt plasmid     template     following oligonucleotides ul9delta535851ecori 5gccgaggtgaattcttactaccggcaccgcagctcccgtagatcg3   5pclpfastbac 5gattattcataccgtcccaccatc3   pcdna3ul9wt plasmid expressing wildtype ul9 under   control     cytomegalovirus promoter was generated   inserting   bamhiecori fragment containing   wildtype ul9 gene   pfastbacul9wt  into   pcdna3 vector invitrogen   pcdna3ul9mi plasmid carrying   k87a mutation   helicase motif   was generated   inserting   bamhiecori fragment   pcdna1ul9mi into   pcdna3 vector   pcdna3ul9mv plasmid was generated   replacing   wildtype ul9 sequence   pcdna3ul9wt   an asciecori fragment containing   g354a mutation   p6ul9mv    pcdna3ul9mimv double mutant was generated   subcloning an asciecori fragment containing   g354a mutation   p6ul9mv into pcdna3ul9mi replacing   corresponding wildtype fragment pcdna3ul9 ntd   pcdnaul9ctd were generated   inserting   bamhiecori fragment   pfastbacul9 ntd   pfastbacul9ctd respectively into   pcdna3 vector   pcdna3ul9delta322851 pcdna3ul9delta355851mv   pcdna3ul9delta450851 plasmids were generated   inserting   asci   ecoridigested pcr fragments containing   corresponding truncations into pcdna3ul9wt replacing   wildtype fragment   pcr fragments were generated   stepdown pcr     pfastbacul9wt plasmid     template   oligoi 5gcggagtcgggagatcctctgggg3     upstream primer   pcdna3ul9delta450851mv truncation was generated     same procedure except     p6ul9mv plasmid was used     template     pcr   specific downstream oligonucleotides used   generate   above truncations were ul9delta322851 5gccgaggtgaattctcattagtccgtaaactgacggcagaaccgggccac3 ul9delta355851mv 5gccgaggtgaattctcattaggccaccgttacgaccgtcgtgtatataaccacgcg3   ul9delta450851 5gccgaggtgaattctcattagcatgccgacgcgtcacagcgccccttgaacc3   pul9eco plasmid containing ul9 under   control   its natural promoter was generously provided   p schaffer university   pennsylvania school   medicine j nellissery kindly provided   pcdna3ul6 plasmid   p6ul9119b plasmid containing   ul9 gene under   control     icp6 promoter was described previously    pcdna3ul9ntau1 plasmid was generated   subcloning an asci   notidigested pcr product into pcdna3ul9wt replacing   corresponding wildtype fragment   pcr product was generated   stepdown pcr     pfastbacul9wt plasmid     template oligoi 5gcggagtcgggagatcctctgggg3     upstream primer   ul9ntau1 5gccggcttctgcggccgctcactatatatagcgatacgtatcatcccggcaccgcagctcccgtatg3     downstream primer   nucleotide sequence encoding   au1 tag   underlined   cloning procedure resulted     addition     au1 tag dtyryi     c terminus   ul9nt   pcdna3au1ul9 plasmid was created   inserting   bamhiecori fragment containing   wildtype ul9 gene into   pcdna3au1 vector resulting     addition   an au1 tag     n terminus   ul9   pcdna3au1 vector was generated   ligation   an au1containing linker     polycloning site via   hindiii   bamhi sites   au1containing linker was created   annealing   bmhbau1  5agcttaccatggatacgtatcgctacatag3   bmhbau1b 5gatcctatgtagcgatacgtatccatggta3 oligonucleotides   nucleotide sequence encoding   au1 tag   underlined  generation   recombinant baculoviruses expressing ul9 variants  recombinant baculoviruses autographa californica nuclear polyhedrosis baculoviruses expressing wildtype    mutant ul9 variants were generated     pfastbac gibcobrl system according     manufacturers instructions  cell lysates  two types   mammalian cell lysates were used     study regular cell lysates were obtained   one 60mm2 plate   was washed   phosphatebuffered saline containing   sigma protease inhibitor cocktail harvested   resuspended   sodium dodecyl sulfatepolyacrylamide gel electrophoresis sdspage loading buffer resulting     total   300 mul   lysate   lysates were boiled   analyzed   western blot analysis concentrated cell lysates were prepared   one 60mm2 plate   was harvested   resuspended   sdspage loading buffer resulting     total   60 mul   fivefoldconcentrated lysate   samples were cupsonicated twice sonicator ultra processor xl misonix inc power setting 9   1 min boiled   analyzed  transient transfectioncomplementation assay    transient transfectioncomplementation assay was performed   described previously  each experiment was repeated three times     mean complementation index was calculated  plaque reduction assay    plaque reduction assay was performed   described previously    brief vero cells   60mm2 plates   50 confluence were cotransfected   wildtype hsv1 infectious dna strain kos     plasmid   interest     ratio   110   lipofectamine plus gibco according     manufacturers recommendations   plates were overlaid   methylcellulose   incubated until plaques were observed plaques were stained   crystal violet   counted each experiment was performed three times     mean number   plaques     standard deviation were calculated  immunofluorescent microscopy  vero cells were transfected   2 mug     plasmid   interest   lipofectamine plus gibco   processed   immunofluorescence 18 h posttransfection   transfected cells were fixed permeabilized   stained   described previously  except     procedures were performed   room temperature   phosphatebuffered saline was supplemented   01 mm cacl2   1 mm mgcl2   reduce cell detachment   primary antibodies were used     following dilutions 17b undiluted rh7 1100 dilution antiicp8 1400 dilution antiau1 1500 dilution   secondary antibodies were used     dilution   1200 images were taken   an olympus bx60 microscope   100x magnification equipped     hamamatsu orca digital camera model c474295   open lab software improvisions images were processed   arranged   adobe photoshop 60   adobe illustrator 70 software
12915576.txt 5   ul9 helicase motif mutants were classified   transdominant   potentiating based     plaque reduction assay     cells were cotransfected   wildtype infectious dna   an excess   ul9encoding plasmid   number   plaques observed   cells transfected   infectious dna only was normalized   100  overexpression   wildtype ul9 slightly reduced   number   plaques     assay 60 compared   100 therefore wildtype ul9   considered inhibitory mutants whose overexpression resulted   significant reduction     plaque number were classified   transdominant   instance   cells transfected   motif   ia ii   vi mutants   number   plaques dropped   10   15   contrast mutants whose overexpression led   increased plaque number were classified   potentiating   cells transfected     motif v mutant   plaque number increased   180    was shown previously     motif v mutant protein was undetectable   mammalian cells transiently transfected     mammalian expression vector under   control     icp6 promoter    protein could   detected   immunoblots   cell lysates   ul9mvtransfected cells   any     available antiul9 antibodies 17b raised against   extreme n terminus r250 recognizing   extreme c terminus   rh7 raised against   whole cterminal domain    addition   mutant carrying   motif v mutation     ob mutation   4aminoacid insertion after residue 591     cterminal domain   ul9   abolishes   originspecific dna function was even   potentiating than   motif v mutant alone   number   plaques     case was increased   220  these results indicated     motif v mutant was capable   influencing   outcome     viral infection   thus must   expressed   least transiently nterminal fragments     fulllength ul9mv protein can   detected   heterologous expression systems    order   determine     motif v mutant protein could   detected   heterologous expression systems ul9mv was expressed   insect cells   recombinant baculoviruses cell lysates   insect cells infected     recombinant virus bearing wildtype ul9     ul9mv mutant were subjected   western blot analysis   antibodies   recognize   extreme n terminus 17b     extreme c terminus r250     ul9 protein both antibodies detected fulllength wildtype ul9 protein fig  lanes 2   5 respectively consistent     previous findings   mammalian cells    fulllength ul9mv protein was observed   17b   r250 antibodies fig  lanes 3   6 respectively surprisingly   17b antibody was able   detect two fragments   approximately 38 kda marked   an arrowhead   30 kda marked   two arrowheads   fragments were detected     antic terminus antibody r250 fig  lane 6   relative amount     30kda fragment varied between different sample preparations suggesting     may     degradation product     38kda fragment   next asked whether   appearance     nterminal fragments   insect cells       mammalian cells reflects different expression levels    stability   these two types   cells   order   determine     previous failure   detect ul9mv was due   expression levels   cloned   ul9mv mutant     mammalian expression vector pcdna3 invitrogen under   control     cytomegalovirus immediateearly promoter   strong constitutive promoter vero cells were transfected     pcdna3ul9mv plasmid     cell lysates were assayed     presence   ul9mv protein   ul9mv fragments   previously seen   vectors     icp6 promoter    protein species were detected   any     antiul9 antibodies data   shown   when concentrated lysates   cells transfected   pcdna3ul9mv were prepared   described   materials   methods   17b antibody detected an nterminal fragment   an apparent mobility   approximately 38 kda fig  lane 4   specific bands were detected     r250 antibody data   shown thus   have demonstrated     both insect   mammalian expression systems   fulllength ul9mv protein   detectable instead an nterminal fragment   similar     identical mobility was observed   both cell types interestingly   fragment     same mobility was observed when ul9mv was cloned   an nterminal   tag   expressed   e coli fig  lane 6   apparent molecular mass     nterminal ul9mv fragment was determined     approximately 38 kda   judged   coomassiestained sdspage gels   benchmark invitrogen   broad range new england biolab molecular weight protein standards thus   appears     similar 38kda band   generated   expression     motif v mutant     three expression systems   propose     g354a mutation results     conformational changes     mutant protein leading     exposure     normally buried protease cleavage sites   difficulties     encountered   detecting   38kda fragment   first may indicate   some     mutant mv protein   degraded completely       clear whether   observed 38kda fragment     result   cleavage     protease present     three cell types   whether   fragment represents   minimal stably folded fragment         result     initial cleavage event  potentiation     due   absence     transdominant originbinding domain   ul9    ul9 cterminal domain ul9 ctd encompassing residues 536   851   transdominant     context     plaque reduction assay      coinfections   wildtype hsv1   recombinant hsv1 expressing   ul9 ctd    transdominant effect     ul9 ctd   abolished     mutation disrupting   originbinding function   introduced  since   c terminus   ul9   clearly transdominant   since   stable cterminal fragments were detected when   potentiating mutant ul9mv was expressed   wanted   rule out   formal possibility     absence     cterminal domain   responsible   potentiation   hypothesized     potentiating phenotype may simply     result     absence     transdominant cterminal portion   ul9     hypothesis   correct   would   expected     nterminal portion   ul9 ul9 ntd lacking   transdominant originbinding domain would   potentiating   order   test   hypothesis   construct expressing   ul9 ntd was generated   tested     plaque reduction assay figure  shows     ul9 ntd was transdominant rather than potentiating interestingly   ul9 ntd protein was   detectable   western blot analysis     17b antibody when used   transfect mammalian cells even   concentrated cell lysates were prepared  suggesting     ul9 ntd   unstable     consistent   previous observations     baculovirus expression system    should   noted   when much larger amounts   plasmid dna were used   transfection   ul9 ntd could   detected   only   very low levels see below   summary   transdominant phenotype   ul9 ntd rules out   possibility   potentiation     result     absence     ul9 ctd  level   transdominance   ul9 ntd correlates   its stability    steadystate protein levels     cell  since   ul9 ntd   unstable   itself while fulllength ul9   stable   reasoned     addition     tag     c terminus     ul9 ntd might improve its stability an au1 tag was added     c terminus     ul9 ntd after residue 534 resulting   ul9 ntdau1 when mammalian cells were transfected     construct   tagged version     n terminus ul9 ntdau1 was readily detected   western blots     17b antibody    well       antiau1 antibody data   shown when ul9 ntdau1 was tested     plaque reduction assay   was found     even   transdominant than   ul9 ntd  transfection experiments   increasing amounts   plasmid dna  demonstrated significant differences     steadystate levels   ul9 ntd   ul9 ntdau1 whereas ul9 ntdau1 was readily observed when 2 mug   plasmid dna was used   transfection ul9 ntd was hardly detectable when 75 mug   plasmid dna was used  although     possible     lower steadystate protein levels   ul9 ntd   due   lower expression levels   consider   unlikely because both pul9ntdau1   pul9ul9ntd were expressed     same promoter   therefore favor   scenario       low steadystate levels     ul9 ntd   due   inherent instability     nterminal fragment   ul9 thus   au1 tag appears   increase   stability     nterminal domain   ul9   summary   have demonstrated     potentiation phenotype   ul9mv     due     absence     cterminal originbinding domain   ul9 furthermore   ul9 ntd   itself   transdominant   its level   transdominance correlates   stability    steadystate protein levels     cell    potentiation phenotype   ul9mv does   depend     helicase activity   ul9    order   test whether   helicase activity   ul9   essential     potentiating phenotype   ul9mv   double mutant ul9mimv carrying   k87a mutation   helicase motif   walker box   was engineered   k87a mutation abolishes   atpase   helicase activities   ul9    ul9mi mutant was previously shown     transdominant     context     plaque reduction assay    double mutant ul9mimv was found     potentiating resulting   approximately   same level   stimulation   viral plaque formation   ul9mv   itself data   shown thus   addition     mi mutation does   affect   potentiation phenotype   ul9mv indicating   potentiation does   rely     helicase activity   ul9  presence     mv g354a mutation   itself     sufficient   potentiation    described above ul9mv potentiation     simply   result     absence     transdominant ctd   ul9     independent     helicase activity     protein therefore   potentiation   most likely   property     g354a mutation itself   order   investigate   hypothesis several ul9 truncations were engineered  ul9delta322851   ends 22 amino acids upstream     g354a mutation ul9delta355851mv   ends immediately after   mv mutation g354a   corresponds     protein fragment   predicted molecular weight close     experimentally determined size     ul9mv fragment observed   mammalian insect   bacterial cells fig    fig  ul9delta450851   ends shortly after   last helicase motif   ul9   contains wildtype sequence   ul9delta450851mv   ends shortly after   last helicase motif   contains   mv mutation g354a     mutants except ul9delta450851mv were found   express proteins     predicted sizes  interestingly   ul9delta450851mv truncation produced   38kda fragment comparable     fragment seen   fulllength ul9mv      plaque reduction assay   truncations except ul9delta450851mv were found     transdominant  ul9delta450851mv was potentiating     level   potentiation was comparable     seen   ul9mv itself    these experiments   appears         trend correlating   potentiation phenotype     plaque reduction assay     ability   ul9 variants     processed   degraded     38kda nterminal fragment   results show     presence     mv mutation   itself     sufficient   confer potentiation   seen     transdominant phenotype     ul9delta355851mv truncation     g354a mutation was sufficient   potentiation     truncation would   expected     potentiating     transdominant   appears     addition     g354a mutation itself   region cterminal     g354a mutation residues 354   450   required   potentiation interestingly neither   g354a mutation nor   region encompassing amino acids 355   450 was sufficient   confer potentiation when present alone   g354a mutation may introduce   conformational change   leads   destabilization     protein   355   450 region may   involved   proteinprotein interactions within   ul9 dimer  overexpression   ul9mv influences wildtype ul9 protein levels     able   override   inhibitory effect   ul9  since   overexpression   wildtype ul9   inhibitory   hsv1 infection   potentiation phenotype   ul9mv may     result   removal   ul9 during   course   infection thereby preventing wildtype ul9   exercising its inhibitory effect   order   test   hypothesis wildtype ul9   ul9mv were cotransfected     ratio   115     steadystate levels   fulllength ul9 were followed   western blot figure  shows     overexpression   ul9mv resulted   lower steadystate levels   wildtype ul9 compare lanes 2   3   order   determine whether destabilization would also occur     context   infection vero cells were transfected   wildtype ul9   ul9mv ratio 115   24 h later were superinfected     ul9 null virus hr94   both experiments shown   fig  lanes 1   4 transfection   fig  lanes 5   8 transfection   hr94 superinfection   level   fulllength ul9 was lowered approximately two   threefold   estimated   control western blots     various amounts   ul9 protein were analyzed   comparison    possibility     decrease   levels   fulllength ul9 protein was due   transfection   large amounts   plasmid   total   16 mug per 60mm2 plate was ruled out   transfecting   cells     same amount   empty plasmid   combination   wildtype ul9 fig  lanes 3   7   order   determine whether   overexpression   ul9mv resulted     decrease   levels   an unrelated protein   same experiment was performed     levels ul6 an hsv1 protein essential   cleavage   packaging were monitored fig  lanes 9   12   overexpression   ul9mv did   lower ul6 steadystate protein levels   summary   found   overexpression   ul9mv reproducibly lowered   levels   wildtype ul9     context   both transfection   infection   ask whether   decrease   steadystate levels   ul9 also correlated     potentiation phenotype   same experiment was performed     context     plaque reduction assay      case vero cells were cotransfected   wildtype hsv1 infectious dna   plasmids encoding wildtype ul9   ul9mv     ratio   110150   shown   fig  wildtype ul9 had an inhibitory effect   plaque formation     overexpression   ul9mv overrode   inhibition interestingly cotransfection   wildtype ul9   ul9mv   wildtype hsv1 infectious dna resulted   even greater plaque numbers compared     same experiment     wildtype ul9 was omitted fig  compare   third   second bars   further stimulation     presence   wildtype ul9 may   due   differences     timing   expression   ul9   plasmids compared   expression     viral genome   may reflect   earlier activation     degradation pathway   acts   lower   steadystate levels   ul9 see below   any case these experiments indicate     potentiation phenotype     ul9mv mutant   inversely related     protein levels   wildtype ul9  indirect evidence   ul9 ntd   ul9mv   able   interact   fulllength ul9    finding   ul9mv lowers   steadystate protein levels   wildtype ul9       steadystate levels   ul6 implies   ul9mv may   capable   proteinprotein interactions   wildtype ul9   addition     possible     ul9 ntd may exert its transdominant phenotype via heterodimerization   wildtype ul9       correct   would   expected     ul9 ntd fragment would   able   form dimers   order   test these hypotheses ul9 ntd   ul9mv proteins were expressed   insect cells   recombinant baculoviruses partially purified   subjected   gel filtration   evaluate their oligomerization state   biochemical approach was unsuccessful due   problems   solubility   protein aggregation   therefore took advantage     knowledge     position     nuclear localization signal nls   ul9    demonstrate proteinprotein interactions   ul9 nls   localized within   last 107 residues     protein  thus   ul9 ntd would   expected     cytoplasmic when transfected alone     ul9 ntd   able   interact   fulllength ul9   would   expected       nucleus when cotransfected   wildtype ul9   experiments show   when transfected alone ul9 ntdau1 was cytoplasmic fig  panels   b   c     was predominantly nuclear when cotransfected   wildtype ul9 fig  panels g h     furthermore   ul9 ntd   wildtype ul9 staining colocalized     nucleus fig  panel     summary since   ul9 ntd   able       nucleus only when cotransfected   wildtype ul9     when transfected alone   conclude     ul9 ntd   able   heterodimerize   wildtype ul9   utilize its nls   similar experiment was performed   ul9mv  when cells were transfected   ul9mv alone nuclear   cytoplasmic staining was observed     17b antibody   recognizes   n terminus   ul9 fig  panel     staining was observed     rh7 antibody raised against   cterminal domain     protein fig  panel b when cells were cotransfected   ul9mv   wildtype ul9   majority   ul9mv was seen     nucleus colocalizing   wildtype ul9 fig  panels g h         experiment   were able   distinguish between   ul9mv protein   wildtype ul9   taking advantage     observation     addition     au1 epitope     n terminus   wildtype ul9 masked   nterminal epitope recognized   monoclonal antibody 17b fig  panel   thus using   tagged version   wildtype ul9 allowed us   differentiate between   n terminus   ul9mv detected     17b antibody     n terminus     au1tagged wildtype ul9 detected     antiau1 antibody       17b control double staining   antiau1   rh7 antibodies showed   au1tagged wildtype ul9 was nuclear fig  panels j   k       staining patterns overlapped fig  panel l ul9mv was both nuclear   cytoplasmic when transfected alone   predominantly nuclear when cotransfected   wildtype ul9   fact     localization   ul9mv     nucleus   improved     presence   fulllength wildtype ul9   consistent   an interaction between them   partial nuclear localization     ul9mv protein     absence   wildtype ul9 may   due     transient expression   fulllength mutant protein   can     nucleus prior   being processed     38kda form alternatively   ul9mv nterminal fragment may     nucleus   diffusion     consider   explanation unlikely due   its size  inhibitory effect   wildtype ul9 depends   level   ul9 protein  previous experiments have suggested     inhibitory effect   wildtype ul9   dose dependent      direct correlation between   actual protein levels   ul9     level   inhibition has   been demonstrated   transfection   increasing amounts wildtype ul9 plasmid     plaque reduction assay results     proportional inhibition   hsv1 infection      these experiments   ul9 protein levels have   been examined   order   show   direct connection between   ul9 protein level   its inhibitory effect   ul9 gene was placed under   control   three promoters   different strengths     ability   each construct   support   growth   hr94   lacz insertion ul9 mutant was investigated     transient transfectioncomplementation assay   ul9 natural promoter     weak promoter     icp6 promoter     relatively strong promoter   requires activation   icp0   vp16   order     transcribed     other hand   cytomegalovirus promoter     strong constitutive promoter figure  shows     was an inverse correlation between   steadystate level   ul9 protein     cell     complementation index   wildtype ul9   inhibitory effects     wildtype ul9 protein   thus   pronounced when larger amounts   protein   present
12915576.txt 6 ul9   believed   play   key role     initiation   viral dna replication     assembly     viral replication machinery     origin   replication   many questions about its precise mode   action have   been answered     paper   demonstrate     inhibition   hsv1 infection can   obtained   overexpression   fulllength ul9   cterminal third     protein containing   originbinding domain     nterminal twothirds   ul9 containing   putative dimerization domain     helicase motifs ii   level   inhibition   hsv1 infection   overexpression   wildtype ul9 correlates directly     steadystate protein levels     ul9 protein itself   iii   mv mutant protein   unstable when expressed   transfection     apparently processed     38kda nterminal fragment   degraded completely potentiation correlates     ability     ul9 variants containing   g354a mutation     processed   degraded     38kda form finally overexpression     mv mutant protein was able   influence   steadystate protein level   wildtype ul9     override   inhibitory effects   wildtype ul9 based     data presented here     previous studies   propose     mv mutant protein   able   interact   fulllength ul9       interaction results     decrease     steadystate level   ul9     turn leads   enhanced viral infection model   transdominance   potentiation   ul9 helicase motif mutants    behavior     ul9 helicase motif mutants     plaque reduction assay    their biochemical properties  can   explained   least   part     twostage model     progression   hsv dna replication previously proposed   us   others    twostage model   depicted schematically   fig    model posits   ul9 binds   origin   replication via its cterminal domain depicted   black circles   propose     binding   ul9   an origin   replication results   origin unwinding   recruitment     rest     replication machinery       direct evidence   indicate whether   initial ul9dependent step occurs via   theta mechanism     some other mechanism later   infection stage ii   propose   replication proceeds   an ul9independent manner   form   head tail concatemers       observed products   viral dna replication consistent     model studies   temperaturesensitive ul9 mutants indicate   ul9   essential     early stages   hsv1 replication   appears     dispensable     later ones    direct evidence exists   answer   question   whether   later stages   replication occur via   recombinationdriven    rollingcircle mechanism   infected cells   insect cells infected   recombinant baculoviruses expressing   hsv replication proteins origincontaining plasmids appeared   replicate     rollingcircle mechanism     mode   replication was inhibited     presence   ul9      other hand replicating dna isolated   mammalian cells has   very complex structure consistent     recombinationmediated mechanism reviewed   references     whether stage ii proceeds   rollingcircle   recombinationdriven replication   both   hsvinfected cells   propose   during   transition between stage     stage ii ul9   removed     origin   replication           pose   physical barrier     progressing replication fork   an excess   ul9   present   predict     origin clearance     delayed   inhibited resulting   lower overall viral titers plaque numbers figure  depicts   model     overexpression   wildtype ul9 inhibits hsv1 replication   inhibiting   progression   stage     stage ii   inhibition appears     mediated   least   part     originbinding function   ul9 since mutations   disrupt origin binding relieve   inhibitory effect   wildtype ul9 overexpression  furthermore   ul9 ctd   transdominant     context     plaque reduction assay      likely     transdominance     ul9 cterminal domain   due   inhibitory effects   both stages   replication   ul9 ctd   known   bind   origin   replication   efficiently   fulllength ul9 therefore   domain would   expected   compete   origin binding   wildtype ul9 originating     hsv1 infectious dna expression levels   ul9 ctd exceeded       fulllength wildtype ul9     experiment therefore ul9 ctd binding     origin would   expected   result     nonproductive complex     origin due     absence     helicase domain     responsible   origin unwinding thus hsv1 replication     inhibited   stage   nevertheless some     hsv1 genomes     bound   wildtype ul9 originating     cotransfected infectious dna   these   result   some stage   intermediates formation   stage ii intermediates however   also   inhibited because     inhibitory effects   ul9 remaining bound     origin    obpc protein described   baradaran et al would also   expected     inhibitory   hsv1 infection because   contains   ul9 originbinding domain      paper   report     n terminus   ul9 can also exert   transdominant effect   hsv1 infection      likely     ul9 ntd inhibits hsv1 replication   stage     virtue   its ability   heterodimerize   fulllength wildtype ul9     consistent   previous reports mapping   dimerization domain   ul9     n terminus      results presented   fig  although   n terminus would   expected   retain helicase activity    transdominant phenotype     ul9 ntd indicates     heterodimer   wildtype ul9   ul9 ntd   probably   capable   unwinding   origin   replication     possible     requirement   ul9   bind   origin     dimer   related     ability   ul9   bind     origin   replication     cooperative manner    any case   appears     transdominance     nterminal domain   ul9 occurs     different mechanism     used     cterminal domain   implications   mapping   dimerization domain   ul9     discussed below   transdominant helicase motif   k87a ia s110t r112a   r113af115a ii e175a   vi r387k mutants  were found     able   dimerize   bind oris   efficiently   wildtype ul9   did   exhibit helicase activity  thus     result     overexpression   mutant protein     context     plaque reduction assay   majority     ul9 present     cell would   expected   consist   dimers   mutant proteins since   mutant homodimers bind   origin   replication   well     wild type does   majority     origins   replication     bound   helicasenegative mutant homodimers therefore stage     likely     inhibited due     absence   helicase activity    addition   progression   stage     stage ii replication would   inhibited     mutant ul9 molecules remaining bound     origin   replication     mechanism similar     inhibition   overexpression   wildtype ul9 described above  although   consider   unlikely   cannot rule out   possibility     inhibitory effect   wildtype ul9     transdominant effect     helicase motif mutants     ul9 ntd also involves   ability   these forms   ul9   interact   other viral    cellular factors needed   hsv1 replication further experiments     necessary   determine whether these potential interactions contribute     transdominance   inhibition   potentiating phenotype     ul9mv mutant   particularly intriguing potentiation     simply   result   removing   originbinding domain   ul9     independent     helicase activity   ul9   three different expression systems   38kda nterminal fragment was observed indicating   fulllength mutant protein   unstable   processed     smaller form     also likely     portion   ul9   degraded completely given   difficulties   have experienced even detecting   38kda fragment     possible   two degradation pathways exist resulting   either complete degradation     formation     38kda fragment       38kda fragment     semistable intermediate     complete degradation pathway although further investigation     needed   distinguish between these possibilities     noteworthy     levels     cellular precursor   nfkappab appear     controlled   two different proteolytic pathways limited processing     50kda protein   complete degradation  despite   fact     fulllength ul9mv protein was observed   any expression system tested     possible   fulllength ul9mv may   transiently expressed     capable   proteinprotein interactions   wildtype ul9   hypothesis   supported     observation     double mutant ul9mvob containing both   g354a   an originbinding mutation was   potentiating than   ul9mv mutant alone  since   ob mutation   an insertion after residue 591     cterminal domain   ul9   order     mutation   have an effect fulllength protein must   synthesized   least transiently interestingly   found   overexpression   ul9mv lowered   wildtype ul9 protein level   overrode   inhibitory effect   wildtype ul9     plaque reduction assay   addition   partial ability     motif v mutant protein       nucleus  suggests     fulllength version     mutant protein may   transiently expressed since   nls   located     very c terminus these data taken together suggest     mv mutant protein   transiently expressed     fulllength protein     capable   interacting   wildtype ul9   influencing both ul9 levels     progression     infection based     results presented     paper     tempting   speculate     expression levels   ul9   regulated     course   infection     possible   ul9 functions early   infection     later   infection     targeted   degradation thus   regulation   steadystate levels   ul9 may play an important role   controlling viral infection posttranslational regulation   protein levels has been shown   play   major role   various cellular processes targeting specific proteins   degradation often through an ubiquitinmediated proteosomal pathway     commonly employed regulatory mechanism   cell cycle progression apoptosis   other biological processes    instance   specific degradation     human cdc6 protein   protein essential   dna replication was recently reported during apoptosis induced   various stimuli cdc6   cleaved   caspase 3 preventing wounded cells   replicating  interestingly ul9 has been shown     phosphorylated during infection although   sites   phosphorylation have   been identified     biological significance     phosphorylation has   been elucidated  furthermore   sequence analysis   ul9 revealed   presence   an internal pest sequence     position near   g354a mutation pest sequences   proline serine   threoninerich motifs   have been shown   target proteins   ubiquitination   degradation often     phosphorylationdependent fashion  taken together these data suggest   possible mechanism     regulation   ul9 through phosphorylation     near   pest sequence     possible   during infection   steadystate levels   ul9   controlled through   ubiquitinmediated pathway   g354a mutation may act   alter   conformation     ul9 protein   exposing   pest sequence   enhancing   degradation   itself     wildtype ul9       can interact   scenario although speculative   consistent     available data further studies     necessary   determine whether   putative pest sequence   phosphorylation play   role     regulation   ul9 levels during infection  implications   ul9 transdominance   ul9 dimerization  since wildtype ul9     dimer   solution      ul9 ctd     monomer    has been assumed     region responsible   dimerization   localized within   nterminal domain   ul9 residues 1   535   attempted   map   dimerization region   ul9   combining deletion analysis   biochemical methods     efforts were hampered     protein insolubility     tested deletions data   shown     paper   showed   immunofluorescent microscopy     ul9 ntd transfected alone   cytoplasmic   contrast when cotransfected   wildtype ul9     imported into   nucleus presumably   ul9 ntd heterodimerizes   wildtype ul9     imported into   nucleus   utilizing   nls located     c terminus   wildtype ul9   result confirms   notion     dimerization determinants   localized     n terminus   ul9     model     transdominance phenotype     ul9 ntd   mediated   dimerization   correct     plaque reduction assay might   used   map   regions   ul9     involved   dimerization   results show     shortest nterminal transdominant fragment     ul9delta322851 truncation suggesting     least one region involved   dimerization may lie within   first 322 amino acids   ul9 further experiments     needed   test   prediction   summary     paper   have shown     first time   direct correlation between   steadystate protein level   ul9     level   inhibition   hsv1 infection transdominance appears     mediated   overexpression originbinding activity   dimerization whereas potentiation   apparently caused     ability     potentiating ul9mv mutant   influence   steadystate levels   wildtype ul9   results suggest   ul9 protein levels   an important factor     progression   hsv1 infection   perhaps subject   regulation
12915576.txt 7 nterminal fragment     fulllength ul9mv protein   detected   insect mammalian   bacterial cells expressing ul9mv nterminal fragment     fulllength ul9mv protein   detected   insect mammalian   bacterial cells expressing ul9mv   western blot analysis   cell lysates   insect cells infected   baculovirus expressing wildtype ul9   ul9mv     17b antibody recognizing   nterminal 35 residues   ul9 lanes 1   3     r250 antibody recognizing   far c terminus   ul9 lanes 4   6 fulllength ul9   marked   an asterisk     nterminal ul9 fragments   marked   single   double arrowheads   molecular size markers 10kda protein ladder   gibco   depicted     right b western blot analysis   cell lysates   insect lanes 1   2 mammalian lanes 3   4   bacterial lanes 5   6 cells expressing   ul9mv mutant   17b antiul9 antibody was used   detection   lanes 1   4   anti  tag india probe was used   detection   lanes 5   6 broad range new england biolabs prestained molecular size markers   depicted     right
12915576.txt 8 ul9 nterminal domain   transdominant ul9 nterminal domain   transdominant     plaque reduction assay   pcdna3ul9nt   control plasmids was performed   described   materials   methods   ul9miexpressing plasmid   shown     representative     transdominant mutant     ul9mvexpressing plasmid was used     representative     potentiating mutant ep empty plasmid np   plasmid   error bars reflect   standard deviation calculated     least three independent experiments b   17b antibody recognizing   nterminal 35 amino acids   ul9 was used   detect ul9 variants   concentrated lysates   cells transfected     plasmids used     plaque reduction assay described   panel   broad range prestained protein markers   depicted     right
12915576.txt 9 level   transdominance   ul9nt depends   its stability    level   expression level   transdominance   ul9nt depends   its stability    level   expression     plaque reduction assay     indicated ul9 ntd variants was performed   described   materials   methods   ul9mvexpressing plasmid was used     representative     potentiating mutant ep empty plasmid np   plasmid   error bars reflect   standard deviation calculated     least three independent experiments b   17b antibody recognizing   nterminal 35 amino acids   ul9 was used   detect ul9 variants   concentrated lysates   cells transfected     plasmids used     plaque reduction assay described fora broad range prestained protein markers   depicted     right c titration     amount   plasmid dna used   transfection   shown   17b antibody detected   protein species   an approximate molecular mass   60 kda   correlates     expected size     ul9 ntd
12915576.txt 10 presence   motif v g354a mutation   itself     sufficient   confer   potentiating phenotype presence   motif v g354a mutation   itself     sufficient   confer   potentiating phenotype   diagram   ul9 truncations   nterminal domain   ul9   depicted   an open box   cterminal domain   ul9   depicted     gray box   ul9 helicase motifs   depicted   black boxes an asterisk points   position     g354a mutation   black line below   ul9 gene depicts   ul9mv nterminal fragment seen   western blot analysis b plaque reduction assays     indicated ul9 truncations were performed   described   materials   methods   ul9mv plasmid was used     representative     potentiating mutant ep empty plasmid np   plasmid   error bars reflect   standard deviation calculated     least three independent experiments c   17b antibody was used   detect ul9 truncations   concentrated lysates   vero cells transfected     plasmids used     plaque reduction assay described   panel   broad range prestained protein markers   depicted     right
12915576.txt 11 overexpression   ul9mv affects   steadystate protein levels   ul9     able   override   inhibitory effect   wildtype ul9     plaque reduction assay overexpression   ul9mv affects   steadystate protein levels   ul9     able   override   inhibitory effect   wildtype ul9     plaque reduction assay   western blot analysis   lysates   cells transfected   pcdna3ul9wt pcdna3ul9mv   pcdna3 empty plasmid ep   17b antiul9 antibody was used   detection   lanes 1   8   polyclonal antiul6 antibody was used   detection   lanes 9   12   fulllength ul9   depicted   an asterisk    ul9mv fragment   depicted   two asterisks  ul6   depicted   an arrowhead   fastermigrating band crossreacting     antiul6 antibody   evident   lanes 9   12 broad range prestained molecular size markers   depicted     right b titration     ul9 amount   cell lysates     17b antibody c   plaque reduction assay     indicated plasmids was performed   described   materials   methods   mean normalized plaque number   standard deviation were calculated     least three independent experiments
12915576.txt 12   nterminal domain   ul9   able   dimerize   nterminal domain   ul9   able   dimerize vero cells were transfected   ul9ntau1 panels   b   c wildtype ul9 panels   e   f   both panels g h       stained   antiau1   rh7 antibodies green fluorescein represents staining   antiau1 antibody red texas red represents staining   rh7 antibody   arrowheads mark untransfected cells     same field   can   used     reference   background staining panels c f       merged images   panels     b     e   g   h respectively
12915576.txt 13 cotransfection   ul9mv   wildtype ul9 results   enhanced nuclear localization cotransfection   ul9mv   wildtype ul9 results   enhanced nuclear localization vero cells were transfected   ul9mv   b   c au1wildtype ul9   e   f   both g h       stained   17b antiul9nt   rh7 antiul9ct antibodies green fluorescein represents staining   17b antibody red texas red represents staining   rh7 antibody   arrowheads mark untransfected cells     same field   can   used     reference   background staining panels c f       merged images   panels     b     e   g   h respectively panels j   k contain images   vero cells transfected   au1wtul9   stained   antiau1   rh7 antibodies green fluorescein represents staining   antiau1 antibody red texas red represents staining   rh7 antibody
12915576.txt 14 inhibitory effect   wildtype ul9 overexpression correlates   ul9 protein levels inhibitory effect   wildtype ul9 overexpression correlates   ul9 protein levels   transient transfectioncomplementation assay was performed   described   materials   methods   bars indicate   mean complementation index   error bars reflect   standard deviation calculated   three independent experiments b western blot analysis   lysates   cells transfected     plasmids used     complementation assay described     legend   panel     r250 antibody was used   detect ul9   polyclonal antitubulin antibody was used     reference   sample loading   has been estimated   lane 2 contains two   threefold less ul9 than lane 3     other hand lane 3 contains 15   2fold less ul9 than lane 4
12915576.txt 15 model     mechanism   potentiationtransdominance     ul9 helicase motif mutants model     mechanism   potentiationtransdominance     ul9 helicase motif mutants   twostage model   hsv1 replication   depicted     center     figure   behavior   wildtype ul9   c   nterminal domains     transdominant motifs   ia ii   vi   shown above   twostage model   cotransfection   these ul9 variants   wildtype infectious dna results   decreased plaque number   shown     downwardfacing arrow parentheses signify   proposed stage   inhibition     viral infection   behavior     potentiating mutant mv   shown below   model   upwardfacing arrows   show both   proposed stage   potentiation     overall increase   plaque number abbreviations   inhibitory td transdominant p potentiating see text   details
12915576.txt 16 
